Herbal supplements: A potential for drug interactions in transplant recipients

被引:72
作者
Barone, GW
Gurley, BJ
Ketel, BL
Abul-Ezz, SR
机构
[1] Univ Arkansas Med Sci, Dept Surg, Little Rock, AR 72205 USA
[2] Univ Arkansas Med Sci, Dept Pharmaceut Sci, Little Rock, AR 72205 USA
[3] Univ Arkansas Med Sci, Dept Med, Little Rock, AR 72205 USA
关键词
D O I
10.1097/00007890-200101270-00012
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Herbal dietary supplements represent a potential and possibly an overlooked cause for drug interactions in transplant recipients. Methods. Two patients are reported which suggest that St. John's Wort (SJW) may induce cytochrome P-450 3A4 activity and/or P-glycoprotein expression. Both of these mechanisms are significantly involved in the metabolism and absorption of cyclosporine (CSA) and other immunosuppressants. Results. After two renal transplant recipients started self-medicating with SJW, their CSA concentrations were consistently documented to be subtherapeutic. While on SJW, one patient developed acute graft rejection due to low CSA concentrations. in both patients, termination of SJW returned their CSA concentrations to therapeutic values. Conclusions. Patients taking SJW concomitantly with CSA or other medications whose absorption and metabolism are mediated by cytochrome P-450 and/or P-glycoprotein should require close monitoring. Potential herb-prescription drug interactions are not just limited to SJW. Inquiries regarding the usage of herbal supplements should be an integral component of a transplant recipient's medication history.
引用
收藏
页码:239 / 241
页数:3
相关论文
共 11 条
[1]  
Crone C C, 1997, J Transpl Coord, V7, P123
[2]   Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum) [J].
Johne, A ;
Brockmöller, J ;
Bauer, S ;
Maurer, A ;
Langheinrich, M ;
Roots, I .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 66 (04) :338-345
[3]   Unsafe and potentially safe herbal therapies [J].
Klepser, TB ;
Klepser, ME .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1999, 56 (02) :125-138
[4]  
LUMPKIN MM, 2000, RISK DRUG INTERACTIO
[5]   Herbal medicinals - Selected clinical considerations focusing on known or potential drug-herb interactions [J].
Miller, LG .
ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (20) :2200-2211
[6]   A METHOD FOR ESTIMATING THE PROBABILITY OF ADVERSE DRUG-REACTIONS [J].
NARANJO, CA ;
BUSTO, U ;
SELLERS, EM ;
SANDOR, P ;
RUIZ, I ;
ROBERTS, EA ;
JANECEK, E ;
DOMECQ, C ;
GREENBLATT, DJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (02) :239-245
[7]   Potential metabolic interaction between St John's wort and theophylline [J].
Nebel, A ;
Schneider, BJ ;
Baker, RK ;
Kroll, DJ .
ANNALS OF PHARMACOTHERAPY, 1999, 33 (04) :502-502
[8]   Indinavir concentrations and St John's wort [J].
Piscitelli, SC ;
Burstein, AH ;
Chaitt, D ;
Alfaro, RM ;
Falloon, J .
LANCET, 2000, 355 (9203) :547-548
[9]   Acute heart transplant rejection due to Saint John's wort [J].
Ruschitzka, F ;
Meier, PJ ;
Turina, M ;
Lüscher, TF ;
Noll, G .
LANCET, 2000, 355 (9203) :548-549
[10]  
SAEKI T, 1993, J BIOL CHEM, V268, P6077